Valeant Buys INova From PE Firms For $688M

By Samuel Howard · November 21, 2011, 1:22 PM EST

Canadian drugmaker Valeant Pharmaceuticals Inc. is enhancing its global presence with the AU$700 million (US$688 million) acquisition of Australia's iNova Pharmaceuticals Pty Ltd. from private equity investors, Valeant announced Sunday....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Samuel

February 08, 2012
PE's Healing Touch Faces Test In Hospital Buys
January 25, 2012
Planned Parenthood Buys NY Headquarters For $35M
January 05, 2012
Schein Buys Oak Hill's Stake In Vet Supply Unit For $155M
November 21, 2011
PE Firm Ratos Sells 2 Cos. To 3D Systems For $137M
November 08, 2011
Goodwin Helps TA Snag Senior Whole Health For $135M
November 01, 2011
Hogan Lovells Guides Glucose Tester In $54M Fundraising
October 20, 2011
VC Firm Pursues Massive $250M Hospital Project In Texas
October 13, 2011
Centurion Shores Up Biotech Outfit With $10M Investment
October 07, 2011
Simpson, Kirkland Aid Investors In $1.6B KCI Notes Deal
September 22, 2011
Skadden Reps Sage In $320M Health Unit Sale To Vista